The efficacy of albumin–globulin ratio to predict prognosis in cancer patients Will S. RobertsWilliam DelladioHoang Nguyen Review Article 08 July 2023 Pages: 1101 - 1111
Effect of a web-based fertility preservation training program for medical professionals in Japan Masanori OnoMiyuki HaradaNao Suzuki Original Article 15 June 2023 Pages: 1112 - 1120
The superselective intra-arterial infusion of cisplatin and concomitant radiotherapy (RADPLAT) is effective for metastatic lymph nodes in head and neck squamous cell carcinoma Satoshi KanoTakayoshi SuzukiAkihiro Homma Original Article 08 June 2023 Pages: 1121 - 1128
Rac1 activation in oral squamous cell carcinoma as a predictive factor associated with lymph node metastasis Masae YamazakiShoichi SekikawaTakeshi Nomura Original Article 07 July 2023 Pages: 1129 - 1138
Site of distant metastasis affects the prognosis with recurrent/metastatic head and neck squamous cell carcinoma patients treated with Nivolumab Yuta HoshiSatoshi ShirakuraTakeshi Beppu Original Article 08 July 2023 Pages: 1139 - 1146
Combined low levels of H4K16ac and H4K20me3 predicts poor prognosis in breast cancer Bo WangMeng ZhouZe-fang Ren Original Article 10 July 2023 Pages: 1147 - 1157
Long-term survival outcome of locally advanced gastric cancer patients who achieved a pathological complete response to neoadjuvant chemotherapy Feilong GuoXiaosong XiangGuoli Li Original Article 15 June 2023 Pages: 1158 - 1165
Phase II clinical trial to study the safety and efficacy of combined S-1 + oxaliplatin therapy as neoadjuvant chemotherapy for locally advanced gastric cancer in older patients Mitsuhiko OtaHiroshi SaekiEiji Oki Original Article Open access 27 June 2023 Pages: 1166 - 1175
Phase I dose-escalation study on irinotecan, cisplatin, and S-1 combination in chemotherapy-naïve patients with HER2-negative advanced gastric cancer (HERBIS-4B, OGSG 1106) Hiroki YukamiHisato KawakamiTaroh Satoh Original Article 07 July 2023 Pages: 1176 - 1182
Severe hypertension development significantly improves progression-free survival in regorafenib treatment for metastatic colorectal cancer Yoshitaka SaitoYoh TakekumaMitsuru Sugawara Original Article 15 June 2023 Pages: 1183 - 1190
Morphological response and tumor shrinkage as predictive factors in metastatic colorectal cancer treated with first-line capecitabine, oxaliplatin, and bevacizumab Tomoyuki NagaokaHiroki OsumiEiji Shinozaki Original Article 22 June 2023 Pages: 1191 - 1199
Clinical characteristics of secondary bladder cancer developing after low-/high-dose-rate brachytherapy to treat localized prostate cancer Keiichiro MiyajimaHirotaka SuzukiTakahiro Kimura Original Article 11 July 2023 Pages: 1200 - 1206
Heterogeneous effects of cytotoxic chemotherapies for platinum-resistant ovarian cancer Katsuhiko NaraAyumi TaguchiYutaka Osuga Original Article Open access 22 June 2023 Pages: 1207 - 1217
Treatment outcomes of the patient with sinonasal mucosal melanoma: the role of endoscopic resection and postoperative radiotherapy Nayuta TsushimaSatoshi KanoAkihiro Homma Original Article 17 June 2023 Pages: 1218 - 1226
Prescription patterns of analgesics in cancer patients with bone metastases in Japan: a retrospective database study Shingo SatoHideyuki TomitoriKyoko Akano Original Article 14 June 2023 Pages: 1227 - 1235
